Medical Developments International Ltd. engages in the manufacture and distribution of pharmaceutical drugs, medical, and veterinary equipment. The firm operates in two segments: Pain Management and Respiratory. The Pain Management segment is engaged in the supply of analgesia for acute and procedural pain. The firm manufactures inhaled analgesic, Penthrox (the Green Whistle), at manufacturing facilities at Scoresby and Springvale in Victoria, Australia. Penthrox is sold into domestic and international markets through distribution partnerships and direct in-market capability. The Respiratory segment is a supplier of respiratory products including asthma and chronic obstructive pulmonary disease (COPD) space chambers, peak flow meters, portable nebulizers and silicone face masks. Respiratory supplies into Australia, the United States of America, Europe, and Asia through partnerships with distributors.
Follow-Up Questions
MDDVF 股票的價格表現如何?
MDDVF 的當前價格為 $0,在上個交易日 decreased 了 0%。
Medical Developments International Ltd 的主要業務主題或行業是什麼?
Medical Developments International Ltd 屬於 Pharmaceuticals 行業,該板塊是 Health Care
Medical Developments International Ltd 的市值是多少?
Medical Developments International Ltd 的當前市值是 $0
Medical Developments International Ltd 是買入、賣出還是持有?
據華爾街分析師稱,共有 3 位分析師對 Medical Developments International Ltd 進行了分析師評級,包括 1 位強烈買入,3 位買入,1 位持有,0 位賣出,以及 1 位強烈賣出